MAGIC Study: More Access to Group Integrative Care
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Jan 25, 2024
Trial Information
Current as of July 15, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Staff and clinicians at each clinic who are involved in implementation of the IMGV.
- • Only patients who have enrolled in the Integrative medical group visit (IMGV) programs for patients with chronic pain at their Federally Qualified Health Center will be eligible for enrollment in the study. Physicians at each clinical site will determine enrollment criteria for their IMGV program specific to their clinical site--patients who are enrolled in the program will then be invited to participate in the research study.
- Exclusion Criteria:
- • All staff, clinicians, and patients who are not involved in the IMGV at the specific clinical sites are excluded from participation.
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Isabel J Roth, DrPH, MS
Principal Investigator
University of North Carolina at Chapel Hill School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported